Bernanke Spurs Stocks
Health Care: Drugs
Array BioPharma Inc. (ARRY: NASDAQ)
$5.80 -0.08 | -1.36%
05/22/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 5.88 |
| 52 Week High | 6.56 |
| 52 Week Low | 3.00 |
| Avg. Daily Vol. (Mil) | 1.12 |
| Beta (3 year) | 1.73 |
| Share Related Items | |
| Mkt Cap (Mil) | 686.64 |
| Shares Out (Mil) | 116.78 |
| Float (Mil) | 85.34 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.60 |
| Current Ratio | 1.70 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | n.a. |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 10.59 |
| Price/Book | 0.00 |
| Price/Cash Flow | -14.40 |
| Per Share Data | |
| Earnings | -0.51 |
| Sales | 0.56 |
| Book Value | 0.00 |
| Cash Flow | -0.41 |
| Business Summary | |
|---|---|
| Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. | |
| General Information | |
| 3200 Walnut Street
Boulder, CO 80301 |
|
| www.arraybiopharma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 250 | |
| CEO: Ron Squarer | |
| Short Interest | |
| Current Month (Mil) | 5.28 |
| Previous Month (Mil) | 4.16 |
| Short Interest Ratio (Days) | 4.30 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -48.70 |
| Return on Investments | -121.00 |
| Profitability | |
| Gross Margin | 61.80 |
| EBIT Margin | -64.30 |
| Profit Margin | -80.70 |
Portfolios with ARRY
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorHot Biotech Stocks Traded b...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Cancer Drug Stocks to Kno...
Latest ARRY Headlines from TheStreet
- 4 Health Care Stocks Under $10 to Watch 04.02.13 | 02:04 pm
- 10 Biotech Stocks With A History Of Beating Earning Expectations 01.10.13 | 07:01 pm
- The Twitterverse's Biotech Stock Picks for 2013 01.02.13 | 08:01 am
- 4 Biotech Stocks Under $10 Moving Higher 11.27.12 | 02:11 pm
- Stocks Finish Tough Week With Slight Gains 11.09.12 | 05:11 pm
- 4 Biotech Stocks Under $10 Soaring Higher 09.25.12 | 02:09 pm
- Stocks Under $10: Blossoming Biotech Play
09.25.12 | 06:09 am - 3 Stocks Under $10 Moving Higher 09.20.12 | 02:09 pm
- Array BioPharma's CEO Presents At Morgan Stanley Healthcare Conference - Transcript 09.10.12 | 04:09 pm
- Array BioPharma's CEO Discusses F4Q2012 Results - Earnings Call Transcript 08.14.12 | 04:08 pm
Press Releases for ARRY
- Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2013 On May 6, 2013 - PR Newswire 04.29.13 | 01:04 pm
- Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting - PR Newswire 12.10.12 | 04:12 pm
- Array BioPharma Announces Pricing Of Public Offering Of Common Stock - PR Newswire 11.09.12 | 08:11 am
- Array BioPharma To Present At The UBS Global Life Sciences Conference - Business Wire 09.11.12 | 05:09 pm
- Array BioPharma Announces Changes To Board Of Directors - Business Wire 08.31.12 | 04:08 pm
- Array BioPharma To Present At The Stifel Nicolaus Healthcare, NewsMakers In The Biotech Industry And Morgan Stanley Global Healthcare Conferences - Business Wire 08.29.12 | 04:08 pm
- Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2012 - Business Wire 08.13.12 | 04:08 pm
- Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2012 On August 13, 2012 - Business Wire 08.06.12 | 05:08 pm
- Array BioPharma’s ARRY-797 Meets Primary Endpoint In Clinical Proof Of Concept Trial In Osteoarthritis Patients Whose Pain Is Poorly Controlled By NSAIDs - Business Wire 07.31.12 | 04:07 pm
- Andrew Robbins, Senior Vice President, Commercial Operations, Array BioPharma (Photo: Business Wire) - Business Wire 07.24.12 | 01:07 pm
Partner Headlines for ARRY
- Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy - Seeking Alpha 05.07.13 | 09:05 am
- Array BioPharma Earnings: Here’s Why Shares are Up Now - Wall St. Cheat Sheet 05.06.13 | 07:05 am
- Array Announces Changes to Board - Benzinga 08.31.12 | 04:08 pm
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.15.12 | 09:08 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 08.13.12 | 09:08 am
- After-Hours Earnings Report for August 13, 2012 : IOC, IAG, WX, ARRY, ANW, LPR, FRF, TSPT, PDII, AMID, FENG, SUMR - NASDAQ 08.13.12 | 04:08 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 08.03.12 | 09:08 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.01.12 | 09:08 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 07.26.12 | 09:07 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 07.20.12 | 09:07 am
